Walvax Biotechnology Co., Ltd. (300142)
Market Closed
16 Oct, 07:00 AM
XSHE XSHE Primary ¥
13. 24
+0.04
+0.303%
¥
19.85B Market Cap
- P/E Ratio
0.01% Div Yield
128.51M Volume
- Eps
¥ 13.2
Previous Close Want to track 300142 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Walvax Biotechnology Co., Ltd. (300142) Statistics
Valuation metrics
Market Cap 19.85B
Enterprise value 24.08B
Trailing P/E (ttm) 125.11
Forward P/E -
PEG ratio 0.1
Price/Sales (ttm) 11.29
Price/Book (mrq) 3.38
Enterprise Value/Revenue 11.52
Enterprise Value/EBITDA 61.68
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 168.62M
Average volume (90 days) 103.87M
Price summary
52-Week low 10.88
52-Week high 16.97
Beta -
50-Day moving average 13.8
200-Day moving average 13.03
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.15
Trailing annual dividend yield 0.0105%
5-Year annual dividend yield -
Payout ratio 1.27
Dividend Date 24 Jun 2026
Ex-Dividend Date 24 Jun 2026
Last split factor 30:10
Last split Date 14 Oct 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.09%
Operating margin 0.06%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.31
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.48
Total debt (mrq) -
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 2.07%
Book value per share (mrq) 4.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
